Brief: New Ray Medicine International Holding Sees Loss Of Over Hk$21 Mln For Six Months
12/08/2022 14:55
Aug 12 (Reuters) - New Ray Medicine International Holding
Ltd 6108.HK :
* SEES LOSS OF OVER HK$21 MILLION FOR SIX MONTHS
* EXPECTED LOSS DUE TO DECREASE IN REVENUE OF MAJOR PRODUCT
UNDER
SECOND GENERATION OF CEPHALOSPORINS
Further company coverage: 6108.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on New Ray Medicine International Holding
See all newsBrief: New Ray Medicine International Holding Says Chu Xueping Resigns As Executive Director
Brief: New Ray Medicine International Posts FY Net Loss Attributable HK$20.1 Million
Brief: New Ray Medicine International To Place Up To 33.4 Million Shares
Brief: New Ray Medicine International Says China New Rich Enters Cooperation Agreement
Brief: New Ray Medicine International Says Unit Disposes 801,000 Jiangxi Rimag Shares For HK$12.8 Million